Skip to main content

ACIU · AC Immune SA · Analyst Estimates

Track ACIU — free
$2.73 -0.09 (-3.02%) At close · Oct 2
Market Cap
$253.54M
Shares
99.43M
Volume · Oct 2 320.26K Avg daily vol (3M) 202.12K

Analyst Estimates

Compare analyst forecasts for AC Immune SA across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-25 13:26 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
CHF
Publication date not stated
-0.495
-0.415
-0.35
—
-0.41033
-0.47633
-0.41033
-0.536
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
1
1
Revenue
CHF
Publication date not stated
16232000
18665000
21200000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
CHF
Publication date not stated
-0.7
0.49567
2.05
—
0.261
0.52767
0.49433
0.52767
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
1
0
Revenue
CHF
Publication date not stated
0
89189940
265000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
CHF
Publication date not stated
-0.182
-0.156
-0.13
—
-0.153
-0.176
-0.153
-0.156
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
2
1
Revenue
CHF
Publication date not stated
0
206250
825000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
CHF
Publication date not stated
-0.182
-0.136
-0.09
—
-0.133
-0.08933
-0.133
-0.136
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
1
1
Revenue
CHF
Publication date not stated
0
7406250
23800000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —
Key facts CIK 1651625 CUSIP H00263105 13F (30d) 1 filings 1 filers Visit website Investor relations